Who is this course for?
Healthcare providers, especially primary care providers for adults and psychiatric health practitioners.
Managing Medical Risk In Patients Seeking Psilocybin Therapy is an online, self-paced course offering healthcare providers comprehensive insights into psilocybin therapy. Gain vital knowledge about psilocybin, its legality, research indications, and learn to manage medical risks in this rapidly evol
Psychedelic Medicine Association
English
5 hours
Managing Medical Risk In Patients Seeking Psilocybin Therapy is a comprehensive 2-hour online, CME/CE accredited course designed for healthcare providers interested in broadening their knowledge about this innovative therapeutic option. This comes in response to the emerging research on the medical benefits of psilocybin and its increased approval for medicinal uses in states like Oregon and Colorado, which have spurred a growing number of patients to consider psilocybin-assisted therapy for various health conditions.
The course aims to fill an information gap in the medical community, as many healthcare professionals have not been trained to effectively assess the medical risks associated with psilocybin therapy. This self-paced program provides participants with the tools they need to safely and comfortably evaluate and discuss the relevant medical risks with their patients.
The curriculum is structured into four key modules: 'Background on Psilocybin', 'Psilocybin Legality & the Oregon Psilocybin Services Act', 'Research-Investigated Indications', and 'Managing Medical Risk in Patients Seeking Psilocybin Therapy'. These modules offer a thorough understanding of the basics of psilocybin therapy, its pharmacology, potential drug-drug interactions, the clinical indications for which it has shown promise, and contraindications to its use. It also explores the historical use of psilocybin and how it affects the mind and body.
This course is especially beneficial for primary care providers for adults and psychiatric health practitioners seeking to deepen their insights into the burgeoning field of psychedelic medicine. Upon completion, participants who pass the course are also offered the opportunity to list themselves in the PMA’s Directory of Psilocybin-Informed Clinicians, a first-of-its-kind directory. This allows patients who need a risk assessment before starting psilocybin therapy to easily find a qualified clinician and offers practitioners a unique platform to connect and share knowledge within a broader community.
Healthcare providers, especially primary care providers for adults and psychiatric health practitioners.
The Psychedelic Medicine Association (PMA) is a professional association that educates and connects healthcare practitioners about the therapeutic use of psychedelic medicines. It also develops clinical practice guidelines, training accreditation, and related infrastructure to support safe integration of psychedelic therapies into mainstream healthcare.
Healthcare providers, especially primary care providers for adults and psychiatric health practitioners.
Format: Self-paced. Time commitment: 5 hours.
The listed price is $100. Confirm the latest tuition, fees, and payment options with [object Object].
Accreditation note: CME. Listed CE/CME credits: 1. Confirm credential eligibility directly with the provider before enrolling.
The current listing status is No New Dates. Use the provider website for the latest enrollment status.
By CIIS
Shares course skills and categories
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Next cohort: Jun 1, 2026
Source lists: Estimated 145 hours
Delivery: Online + San Francisco, United States + Portland, United States
Includes medicine self-experience
By Shift
Shares course skills and categories
Embark on a 7-week journey with The Magic Mushroom Course. Led by expert Christopher Hobbs, this course offers a comprehensive guide to the therapeutic and transformative potential of psilocybin mushrooms
By PRATI
Shares course skills and categories
PRATI’s Ketamine-Assisted Psychotherapy (KAP) Training Program is a comprehensive four-day course designed for mental health and medical professionals who are interested in exploring the transformative potential of psychedelic therapy.
Next cohort: Jul 13, 2026
Self-paced access
Source lists: Estimated 80 hours
Delivery: Self-paced + Online
Includes medicine self-experience